Guanze Medical Information Industry (Holding) Co., Ltd.
2427.HK
Hong Kong Stock Exchange2.71
HKD
-0.31
- -
ISIN
KYG4315D1060
Return %
Stock
S&P500
1Y
708.96
20.98
3Y
613.16
70.79
5Y
54.86
73.45
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Xianzhen Meng
- Full Time Employees
- 56
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Address
- Strategic Emerging Industry Base Jinan People's Republic of China
- IPO Date
- Dec 29, 2022
- Website
- guanzegroup.com
- Similar Companies
- Business
- Guanze Medical Information Industry (Holding) Co., Ltd. engages in the provision of medical imaging solutions in the People's Republic of China, with a focus on medical imaging film products and cloud-based imaging services. The company operates as an investment holding entity, with core activities centered on the research, development, sale, and maintenance of medical imaging materials and associated information technology platforms. Headquartered in Jinan, China, Guanze maintains a corporate structure that includes subsidiaries dedicated to manufacturing and distributing imaging films, as well as delivering cloud-based medical imaging solutions and related digital platforms. The firm markets imaging films to hospitals and healthcare institutions, while also offering digital medical imaging cloud storage platforms, digital image platforms, regional imaging diagrams platforms, and Picture Archiving and Communication System (PACS) solutions. Additional revenue streams arise from the sale of self-service film output printers, medical image printers, and data distribution systems, alongside maintenance and leasing of medical devices. The company’s operations span across China, with strategic emphasis on expanding market presence in Shandong Province and broader eastern regions, leveraging brand promotion, industry exhibitions, and IT system upgrades to enhance service delivery. Guanze was founded in 2015 and is publicly listed on the Hong Kong Stock Exchange (ticker: 2427.HK), with a corporate headquarters in Jinan and an implied corporate structure that includes a Cayman Islands entity as the primary holding vehicle. The company’s geographic footprint includes mainland China operations and related regional service networks, aiming to serve hospitals, clinics, and other healthcare providers with integrated imaging film products and cloud-based imaging services. The latest major changes include strategic expansions in product offerings and value chain development, ongoing acquisitions and registrations to broaden device capabilities, and initiatives to upgrade IT systems and broaden market reach through exhibitions and brand initiatives.